British Journal of Clinical Pharmacology

Early human studies of investigational agents: dose or microdose?
pp. 277-279(3)
Author: Lewis, Lionel D.

Pharmacokinetics and response of obese patients with chronic hepatitis C treated with different doses of PEG-IFN α-2a (40KD) (PEGASYS^®)
pp. 280-287(8)
Authors: Bressler, Brian; Wang, Ka; Grippo, Joseph F.; Heathcote, E. Jenny

A pharmacokinetic evaluation of five H₁ antagonists after an oral and intravenous microdose to human subjects
pp. 288-298(11)
Authors: Madan, Ajay; O'Brien, Zhihong; Wen, Jianyun; O'Brien, Chris; Farber, Robert H.; Beaton, Graham; Crowe, Paul; Oosterhuis, Berend; Garner, R. Colin; Lappin, Graham; Bozigian, Haig P.

Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects
pp. 299-308(10)
Authors: Patat, Alain; Parks, Virginia; Raje, Sangeeta; Plotka, Anna; Chassard, Didier; Coz, F. Le

Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers
pp. 309-315(7)
Authors: Bryson, Andrew; de la Motte, Stephan; Dunk, Christopher

Pain on injection with microemulsion propofol
pp. 316-325(10)
Authors: Sim, Ji-Yeon; Lee, Soo-Han; Park, Do-Yang; Jung, Jin-Ah; Ki, Kyoung-Ho; Lee, Dong-Ho; Noh, Gyu-Jeong

Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection
pp. 326-332(7)
Authors: Tsai, Jai-Jen; Hsu, Yao-Chun; Perng, Chin-lin; Lin, Hwai-Jeng

Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects
pp. 333-340(8)
Authors: Micallef, Joëlle; Rey, Marc; Eusebio, Alexandre; Audebert, Christine; Rouby, Frank; Jouve, Elisabeth; Tardieu, Sophie; Blin, Oliver

Access to prescribing information for paediatric medicines in the USA: post-modernization
pp. 341-346(6)
Authors: Young, Larissa; Lawes, Francis; Tordoff, June; Norris, Pauline; Reith, David

Clinically relevant QTc prolongation due to overridden drug-drug interaction alerts: a retrospective cohort study
pp. 347-354(8)
Authors: van der Sijs, Heleen; Kowlesar, Ravi; Klootwijk, A. Peter J.; Nelwan, Stefan P.; Vulto, Arnold G.; van Gelder, Teun

Statin treatment in a cohort of 20 212 men and women in Norway according to cardiovascular risk factors and level of education
pp. 355-362(8)
Authors: Selmer, Randi; Sakshaug, Solveig; Skurtveit, Svetlana; Furu, Kari; Tverdal, Aage

Evaluation of cost of treatment of drug-related events in a tertiary care public sector hospital in Northern India: a prospective study
pp. 363-369(7)
Authors: Pattanaik, Smita; Dhamija, Punit; Malhotra, Samir; Sharma, Navneet; Pandhi, Promila

How well are general practice trainees prepared for paediatric prescribing?
pp. 370-373(4)
Authors: Isa, N. M.; Taylor, Michael W.; Helms, Peter J.; McLay, James S.

Lack of effect of subject posture on intravenous midazolam clearance: implications for hepatic cytochrome P450 3A phenotyping
pp. 374-375(2)
Authors: Ma, Joseph D.; Nafziger, Anne N.; Mylott, William; Haughey, David B.; Rocci Jr, Mario L.; Bertino Jr, Joseph S.

Translation Section
pp. 376-382(7)